Dose escalation vs. continued doses of paroxetine and maprotiline: a prospective study in depressed out-patients with inadequate treatment response.
- 1 April 1997
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 95 (4), 288-296
- https://doi.org/10.1111/j.1600-0447.1997.tb09634.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tricyclic Antidepressant Concentrations in PlasmaJournal of Clinical Psychopharmacology, 1994
- A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive DisorderArchives of General Psychiatry, 1994
- Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effectsEuropean Neuropsychopharmacology, 1993
- ParoxetineInternational Clinical Psychopharmacology, 1992
- A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed OutpatientsInternational Clinical Psychopharmacology, 1992
- Fluoxetine in the Treatment of Bulimia NervosaArchives of General Psychiatry, 1992
- National Institute of Mental Health Treatment of Depression Collaborative Research ProgramArchives of General Psychiatry, 1989
- The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of DepressionThe British Journal of Psychiatry, 1988
- The Importance of Dosage in Prescribing AntidepressantsThe British Journal of Psychiatry, 1985
- MaprotilineDrugs, 1977